143 related articles for article (PubMed ID: 12602497)
1. Development of a novel soft hydrogel for the transdermal delivery of testosterone.
An NM; Kim DD; Shin YH; Lee CH
Drug Dev Ind Pharm; 2003 Jan; 29(1):99-105. PubMed ID: 12602497
[TBL] [Abstract][Full Text] [Related]
2. The effects of pressure-sensitive adhesives and solubilizers on the skin permeation of testosterone from a matrix-type transdermal delivery system.
Zhao H; Park DW; Kim SK; Lee CH; Kim DD
Drug Dev Ind Pharm; 2002 Oct; 28(9):1125-31. PubMed ID: 12455471
[TBL] [Abstract][Full Text] [Related]
3. Synergic enhancing-effect of DEET and dodecylamine on the skin permeation of testosterone from a matrix-type transdermal delivery system.
Zhao H; Choi MK; Kim JS; Yong CS; Choi HG; Chung SJ; Shim CK; Kim DD
Drug Deliv; 2009 Jul; 16(5):249-53. PubMed ID: 19538005
[TBL] [Abstract][Full Text] [Related]
4. Formulation of a reservoir-type testosterone transdermal delivery system.
Kim MK; Zhao H; Lee CH; Kim DD
Int J Pharm; 2001 May; 219(1-2):51-9. PubMed ID: 11337165
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of a novel nonscrotal matrix-type transdermal delivery system of testosterone.
Zhao H; Lee CH; Chung SJ; Shim CK; Kim DD
Drug Dev Ind Pharm; 2005 Mar; 31(3):257-61. PubMed ID: 15830721
[TBL] [Abstract][Full Text] [Related]
6. Effect of sonophoresis and chemical enhancers on testosterone transdermal delivery from solid lipid microparticles: an in vitro study.
El-Kamel AH; Al-Fagih IM; Alsarra IA
Curr Drug Deliv; 2008 Jan; 5(1):20-6. PubMed ID: 18220547
[TBL] [Abstract][Full Text] [Related]
7. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines.
Aungst BJ; Blake JA; Hussain MA
Pharm Res; 1990 Jul; 7(7):712-8. PubMed ID: 2395798
[TBL] [Abstract][Full Text] [Related]
8. Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization.
El-Kamel AH; Al-Fagih IM; Alsarra IA
J Microencapsul; 2007 Aug; 24(5):457-75. PubMed ID: 17578735
[TBL] [Abstract][Full Text] [Related]
9. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
10. Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women.
Zeng J; Xie TF; Huang T; Li F; Wang ZP; Feng LL
AAPS PharmSciTech; 2022 Feb; 23(3):79. PubMed ID: 35212788
[TBL] [Abstract][Full Text] [Related]
11. Effects of adhesives and permeation enhancers on the skin permeation of captopril.
Park ES; Chang SJ; Rhee YS; Chi SC
Drug Dev Ind Pharm; 2001 Oct; 27(9):975-80. PubMed ID: 11763476
[TBL] [Abstract][Full Text] [Related]
12. Skin permeation enhancement of diclofenac by fatty acids.
Kim MJ; Doh HJ; Choi MK; Chung SJ; Shim CK; Kim DD; Kim JS; Yong CS; Choi HG
Drug Deliv; 2008 Aug; 15(6):373-9. PubMed ID: 18686081
[TBL] [Abstract][Full Text] [Related]
13. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
14. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
16. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
17. Improved Skin Penetration Using In Situ Nanoparticulate Diclofenac Diethylamine in Hydrogel Systems: In Vitro and In Vivo Studies.
Sengupta S; Banerjee S; Sinha B; Mukherjee B
AAPS PharmSciTech; 2016 Apr; 17(2):307-17. PubMed ID: 26089167
[TBL] [Abstract][Full Text] [Related]
18. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
[TBL] [Abstract][Full Text] [Related]
19. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
20. Synergistic enhancement of testosterone transdermal delivery.
Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
